In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Takeda Pharmaceutical Co. Ltd.

http://www.takeda.com

Latest From Takeda Pharmaceutical Co. Ltd.

Finance Watch: Venture Rounds Trend Toward The High End

Private Company Edition: First quarter data again confirm fewer but larger VC rounds in Q1. Big Q2 rounds include a $132.5m series C round for Endeavor Biomedicines, a $103m series A round for Reunion Neuroscience and Enlaza’s $100m series A.

Financing Innovation

Astellas Stakes Claim In CAR-Ts For Solid Tumors With Poseida Deal

Astellas is building off an existing relationship with the biotech formed last August, joining the growing number of large pharmas looking at tackling solid tumors with cell therapy.

Deals ImmunoOncology

Analysis: Novo And Lilly Make Their Money Work

Pharma groups must decide how best to invest their cash to generate the biggest returns, and while huge sums can be made with luck and good judgement, strategic missteps can have far-reaching consequences.

Companies Strategy

Idorsia’s Novel Hypertension Pill Among Eight New Drugs To Win EMA Nod

The European Medicines Agency believes Idorsia’s Jeraygo should be approved for use in the EU at two different doses rather than just the one approved by the US Food and Drug Administration last month.

Europe Approvals
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Adaptate Biotherapeutics Ltd
    • Altos Therapeutics LLC
    • AR Scientific, Inc. (URL)
    • ARIAD Pharmaceuticals, Inc.
    • Bradley Pharmaceuticals, Inc
    • Cellerix SA
    • Cerevance, Envoy Therapeutics, Inc.
    • Chordia Therapeutics
    • ChromaJean, Inc.
    • GammaDelta Therapeutics
    • IDM Pharma
    • Intellikine, Inc.
    • Inviragen, Inc.
    • LigoCyte Pharmaceuticals, Inc.
    • Maverick Therapeutics, Inc.
    • Millennium Pharmaceuticals, Inc.
    • Mutual Pharmaceutical Company, Inc. (URL)
    • Neutec
    • Nihon Pharmaceutical Co., Ltd
    • Nycomed Pharma AS
    • Pharmaceutical Holdings Corporation (URL)
    • PvP Biologics, Inc.
    • sanaplasma AG
    • Syrrx, Inc.
    • TAP Pharmaceutical Products, Inc.
    • Teva Takeda Pharma Ltd.
    • Shire Pharmaceuticals Group PLC (SHPG)
    • Teva Takeda Yakuhin Ltd.
    • TiGenix NV
    • URL Pharma, Inc. Advanced BioHealing, Inc. (renamed Shire Regenerative Medicine)
    • AesRX LLC
    • Baxalta Incorporated
    • BIKAM Pharmaceuticals Inc.
    • Chatham Therapeutics
    • Dyax Corp.
    • FerroKin BioSciences, Inc.
    • Fibrotech Therapeutics
    • Foresight Biotherapeutics Inc.
    • Gambro AB
    • Immuno-US
    • Jerini AG
    • Lotus Tissue Repair
    • Lumena Pharmaceuticals
    • Meritage Pharma, Inc.
    • Movetis NV
    • New Pervasis Therapeutics, Inc.
    • NPS Pharmaceuticals, Inc.
    • Premacure AB
    • Prism Pharmaceuticals, Inc.
    • River Pharmaceuticals
    • Roberts Pharmaceutical Corporation
    • SARcode Corporation
    • SuppreMol GmbH
    • Synovis Life Technologies, Inc.
    • Transkaryotic Therapies, Inc.
    • ViroPharma Inc.
UsernamePublicRestriction

Register